Medications

FDA approves new drug to protect against RSV in infants

Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year.

Diseases, Conditions, Syndromes

Air monitor can detect COVID-19 virus variants in about 5 minutes

Now that the emergency phase of the COVID-19 pandemic has ended, scientists are looking at ways to surveil indoor environments in real time for viruses. By combining recent advances in aerosol sampling technology and an ultrasensitive ...

Diseases, Conditions, Syndromes

Australia is in another COVID wave, but it's not like the others

Each omicron wave so far in Australia has had distinguishing features—the sharp rise and fall of BA.1, the widespread transmission among children and families in BA.2, a shift to more infections in older people with BA.5, ...

Diseases, Conditions, Syndromes

EU approves first vaccine against common respiratory virus

The European Commission has followed the United States in approving the world's first vaccine for the Respiratory Syncytial Virus, to be used by adults aged 60 and over, its maker GlaxoSmithKline said Wednesday.

Diseases, Conditions, Syndromes

US approves second RSV vaccine

The US drug regulator approved a second vaccine against respiratory syncytial virus (RSV), its American developer Pfizer said Wednesday, a month after the authorization of the first shot against the pathogen, a leading cause ...

page 11 from 40